Defence Therapeutics Inc. Defence Therapeutics Inc.

Defence Therapeutics Inc.

DTC

Classificação em ações #29780
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Preço da ação
$0.24953854
Última sincronização: 2026-10-16
Valor de mercado
$18.91M
Variação (1 dia)
-5.56%
Variação (1 ano)
-53.23%
País
CA
Negociar Defence Therapeutics Inc. (DTC)

Categoria

Healthcare
Preço DTC com a capitalização de mercado de B
Defence Therapeutics Inc. Defence Therapeutics Inc.
DTC
$0.24953854
Capitalização de mercado de Defence Therapeutics Inc.(DTC)
Valor de mercado: $18.91M
Em October 2026, Defence Therapeutics Inc. tem uma capitalização de mercado de $18.91M. Isso faz com que Defence Therapeutics Inc. seja a 29780th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Defence Therapeutics Inc. de 2021 a 2026
DTC comparado com o topo de 5 mais populares stocks
Preço para DTC Ativo B Capitalização de mercado de B Resultados
Defence Therapeutics Inc. Defence Therapeutics Inc.
$68,177.37 $18.79M
$5.167T +27,501,863.69%
Defence Therapeutics Inc. Defence Therapeutics Inc.
$66,168.34 $18.79M
$5.015T +26,691,443.78%
Defence Therapeutics Inc. Defence Therapeutics Inc.
$54,209.00 $18.79M
$4.108T +21,867,183.56%
Defence Therapeutics Inc. Defence Therapeutics Inc.
$51,484.32 $18.79M
$3.902T +20,768,079.75%
Defence Therapeutics Inc. Defence Therapeutics Inc.
$35,486.47 $18.79M
$2.689T +14,314,734.49%